The Novel Anti-CD40 Monoclonal Antibody CFZ533 Shows Beneficial Effects in Patients with Primary Sjogren's Syndrome: A Phase IIa Double-Blind, PlaceboControlled Randomized Trial
Benjamin Fisher,Margit Zeher,Wan-Fai Ng,Michele Bombardieri,Maximilian Posch,Athena S. Papas,Arwa M. Farag,Thomas Daikeler,Bettina Bannert,Alan J. Kivitz,Steven E. Carsons,David A. Isenberg,Francesca Barone,Simon Bowman,Pascal Espie,Grazyna Wieczorek,Pierre Moulin,David Floch,Cyrielle Dupuy,Xiaohui Ren,Petra Faerber,Andrew M. Wright,Hans Ulrich Hockey,Michael Rotte,James S. Rush,Peter Gergely ARTHRITIS & RHEUMATOLOGY(2017)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)